Pharmaceutical executive and scientist with strong entrepreneurial drive. Exhibited successes in building a therapeutic research unit de novo and leading discovery and clinical development of biological (vaccines, biopharmaceuticals) and small molecule medicines across several therapeutic areas. With creativity and a strong results-focus, energized to challenge and lead teams.
Extensive Pharmaceutical industry experience spans drug discovery and development across several therapeutic areas and disciplines. Leadership in conceptualizing and developing collaborations between GSK and Academic Institutes and Biotechs (Corixa, Exelixis, ChemoCentryx, OncoMed). Accountable for the discovery and development of GSK’s Ophthalmic Drug portfolio. Built scientific networks in HIV vaccine discovery, Immuno-Oncology and Ophthalmology. International work experience with fluency in English, French and German.
Most recent experience was forming and raising investment for AtenVision, a GSK spin-out to bring forward projects left behind when GSK’s closed its Ophthalmology unit for strategic/financial reasons.